Yep IMO we are holding pretty well. That share holder needs to look at DXB, CHM, RAD, PTX, NYR to name a few. The list is plenty in the biotech sector been hammered in the last 12 to 24 months. Frustrating as it is for some share holders we all need to look at the longer term bigger picture for AGN.
Ann: Final Phase1 Clinical Trial Report, page-13
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
75.5¢ |
Change
-0.015(1.95%) |
Mkt cap ! $96.71M | |||
| Open | High | Low | Value | Volume |
| 78.0¢ | 78.0¢ | 75.0¢ | $42.02K | 55.50K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 33770 | 74.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.0¢ | 10243 | 4 |
View Market Depth
| Last trade - 13.10pm 04/11/2024 (20 minute delay) ? |
| AGN (ASX) Chart |